University of Arkansas receives $3.1 million NIH award to study pediatric mitochondrial disorders

Si­mone Song re­calls dis­cussing on­colyt­ic virus ther­a­pies with her fa­ther and son “un­der the moon­light, like a fam­i­ly sci­en­tif­ic sym­po­sium” in South­ern Cal­i­for­nia in 2014.

The FDA’s ad­vi­so­ry com­mit­tees of out­side ex­perts typ­i­cal­ly re­view con­tro­ver­sial drug ap­proval de­ci­sions at meet­ings sched­uled months in ad­vance. But the agency’s ad­comm cal­en­dar for

10x Ge­nomics has seen “in­cred­i­ble trac­tion” with its newest prod­uct, Xe­ni­um, ship­ping over 100 an­a­lyz­ers since launch­ing less than a year ago, CEO Serge Sax­onov